Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 6NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Rectal Neoplasms 1

Interventions

Fluorouracil 20Leucovorin 18Oxaliplatin 11Irinotecan 10Capecitabine 6Bevacizumab 5Cetuximab 4Levamisole 3Celecoxib 3cediranib 2Watchful Waiting 2Tegafur 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Folfox protocol 2Counseling 2Cisplatin 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1regorafenib 1pertuzumab 1olaparib 1mercaptoundecahydrododecaborate 1gevokizumab 1eniluracil 1cemiplimab 1brivanib 1alpha-Tocopherol 1Vitamin E 1Uracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Colonic Neoplasms × Tegafur × Clear all
NCT00004860 2023-06-15

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00378716 2010-01-11

Combination Chemotherapy in Treating Patients With Resected Colon Cancer

NSABP Foundation Inc

Phase 3 Completed
1,608 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡